Artivion | CRY - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Abbott USD 2.39B 27M 2026-03
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Boston Scientific USD 1.42B 261M 2026-06
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Inogen USD -6.06M 467K 2024-09
Integra LifeSciences USD -2.41M 6.72M 2026-03
J&J USD 8.66B 839M 2026-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -2.19M 20.07M 2025-12
Pfizer USD -653M 5.84B 2026-06
ResMed USD 502.31M 6.16M 2026-03
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD -19.88M 24.56M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
Terumo JPY 90.32B 58.66B 2026-06
Trinity Biotech USD -5.06M 10.74M 2025-09